检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:赫捷 陈万青 李兆申 李霓 任建松 田金徽[3] 田文静[4] 胡付兰 彭绩[6] 中国胃癌筛查与早诊早治指南制定专家组 中国胃癌筛查与早诊早治指南制定工作组 HE Jie;CHEN Wan-qing;LI Zhao-shen;LI Ni;Ren Jian-song;TIAN Jin-hui;TIAN Wen-jing;HU Fu-lan;PENG Ji;Expert Group of China Guideline for the Screening,Early Detection and Early Treatment of Gastric Cancer;Working Group of China Guideline for the Screening,Early Detection and Early Treatment of Gastric Cancer(National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;The First Affiliated Hospital of Naval Medical University,Shanghai 200433,China;Evidence-Based Medicine Center,Lanzhou University,Lanzhou 730000,China;Public Health College of Harbin Medical University,Harbin 150081,China;School of Public Health,Shenzhen University Health Science Center,Shenzhen 518037,China;Shenzhen Centre for Chronic Disease Control,Shenzhen 518020,China;不详)
机构地区:[1]国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院,北京100021 [2]海军军医大学第一附属医院,上海200433 [3]兰州大学循证医学中心,甘肃兰州730000 [4]哈尔滨医科大学公共卫生学院,黑龙江哈尔滨150081 [5]深圳大学医学部公共卫生学院,广东深圳518037 [6]深圳市慢性病防治中心,广东深圳518020 [7]不详
出 处:《中国肿瘤》2022年第7期488-527,共40页China Cancer
摘 要:胃癌是我国常见的恶性肿瘤之一,严重威胁我国居民生命健康。胃癌高风险人群接受筛查和早诊早治能够有效降低胃癌的发病率和死亡率。制定符合中国国情的胃癌筛查与早诊早治指南,将促进中国胃癌筛查的同质性和规范性,提高胃癌筛查的效果。中国胃癌筛查与早诊早治指南受国家卫生健康委员会疾病预防控制局的委托与指导,由国家癌症中心发起,联合多学科专家,整合胃癌筛查与早诊早治领域的国内外研究进展,同时考虑中国国情和胃癌筛查的实际经验,根据世界卫生组织推荐的指南制定原则和方法,针对胃癌筛查过程中的筛查人群、技术、流程等给出了基于证据的推荐,旨在保证胃癌筛查与早诊早治效果,为中国的胃癌防控提供科学依据。Gastric cancer(GC) is a major digestive tract malignancy in China, which seriously threatens the health of Chinese population. A large number of researches have demonstrated that screening, early detection and early treatment are effective in reducing the incidence and mortality of GC. The development of the guideline for GC screening, early detection and early treatment in line with epidemic characteristics of GC in China will greatly promote the homogeneity and standardization, and improve the effect of GC screening. This guideline was commissioned by the Bureau of Disease Control and Prevention of the National Health Commission. The National Cancer Center of China initiated and convened a working group comprising multidisciplinary experts. Following the World Health Organization Handbook for Guideline Development, this guideline combined the most up-to-date evidence of GC screening, China’s national conditions, and practical experience in cancer screening. This guideline provided evidence-based recommendations with respect to the screening population, technology and procedure management, aiming to improve the effect of GC screening and provide scientific evidence for the GC prevention and control in China.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.229